Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine.
Saved in:
| Title: | Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine. |
|---|---|
| Authors: | Folschweiller N; GSK, Wavre, Belgium., Behre U, Dionne M; Centre Hospitalier Universitaire, Québec., Durando P; Department of Health Sciences, University of Genoa.; IRCCS Ospedale Policlinico AOU San Martino-IST, Genoa., Esposito S; Pediatric Clinic, Department of Surgical and Biomedical Sciences, Università degli Studi di Perugia, Perugia, Italy., Ferguson L; Colchester Research Group, Truro., Ferguson M; Colchester Research Group, Truro., Hillemanns P; MedizinischeHochschule Hannover; Hannover., McNeil SA; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax., Peters K, Ramjattan B; First Line Medical Services, St. John's, Canada., Schwarz TF; Institute of Laboratory Medicine and Vaccination Centre, Klinikum Würzburg Mitte, Standort Juliusspital, Würzburg, Germany., Supparatpinyo K; Chiang Mai University, Thailand., Suryakirian PV; GSK, Bangalore, India., Janssens M; GSK, Wavre, Belgium., Moris P; GSK, Wavre, Belgium., Decreux A; GSK, Wavre, Belgium., Poncelet S; GSK, Wavre, Belgium., Struyf F; GSK, Wavre, Belgium. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2019 May 05; Vol. 219 (11), pp. 1799-1803. |
| Publication Type: | Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
